Company Thermo Fisher Scientific, Inc.
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 472.80 USD | -1.91% |
|
-4.00% | -18.41% |
| 06-03 | Thermo Fisher Scientific Shares Fall After HSBC Downgrade | MT |
| 06-03 | HSBC Downgrades Thermo Fisher Scientific to Hold From Buy, Adjusts Price Target to $540 From $670 | MT |
Business description: Thermo Fisher Scientific, Inc.
- laboratory equipments (73.2%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.;
- scientific analysis equipments (16.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc.;
- diagnostics equipment and products (10.1%).
Net sales break down by source of revenue between sales of products (58.4%) and services (41.6%).
Net sales break down geographically as follows: North America (52.5%), Europe (25.3%), Asia/Pacific (18.6%) and other (3.6%).
Number of employees: 125,000
Sales by Activity: Thermo Fisher Scientific, Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Laboratory Products and Biopharma Services | 14.86B | 22.51B | 23.04B | 23.16B | 23.98B |
Analytical Instruments | 6.07B | 6.62B | 7.26B | 7.46B | 7.55B |
Life Sciences Solutions | 15.63B | 13.53B | 9.98B | 9.63B | 10.37B |
Specialty Diagnostics | 5.66B | 4.76B | 4.4B | 4.51B | 4.68B |
Eliminations | -3.01B | -2.52B | -1.83B | -1.88B | -2.03B |
Geographical breakdown of sales: Thermo Fisher Scientific, Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Other Regions | 16.86B | 17.3B | 20.84B | 21.12B | 22.32B |
United States | 18.91B | 23.82B | 22.01B | 21.76B | 22.24B |
China | 3.44B | 3.79B | - | - | - |
Executive Committee: Thermo Fisher Scientific, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 58 | 14/10/2009 |
Jim Meyer
DFI | Director of Finance/CFO | 46 | 28/02/2026 |
Gianluca Pettiti
PSD | President | 47 | 28/02/2026 |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2018 |
Sebastian Pacios
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2023 |
Composition of the Board of Directors: Thermo Fisher Scientific, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 68 | 08/11/2006 |
Marc Casper
CHM | Chairman | 58 | 25/02/2020 |
Tyler Jacks
BRD | Director/Board Member | 65 | 25/05/2009 |
Nelson Chai
BRD | Director/Board Member | 60 | 09/12/2010 |
C. Harris
BRD | Director/Board Member | 69 | 29/03/2012 |
Dion Weisler
BRD | Director/Board Member | 58 | 28/02/2017 |
Debora Spar
BRD | Director/Board Member | 62 | 04/09/2019 |
R. Keith
BRD | Director/Board Member | 58 | 19/11/2020 |
Ruby Chandy
BRD | Director/Board Member | 64 | 28/02/2022 |
Jenny Johnson
BRD | Director/Board Member | 61 | 12/07/2023 |
Holdings: Thermo Fisher Scientific, Inc.
| Name | Equities | % | Valuation |
|---|---|---|---|
| 1,959,200 | 5.8% | 4 M $ |
Company details: Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
168 Third Avenue
02451, Waltham
+781 622 1000
http://www.thermofisher.com
Group companies: Thermo Fisher Scientific, Inc.
| Name | Category and Sector |
|---|---|
PharmaFluidics NV
 PharmaFluidics NV Electronic Equipment/InstrumentsElectronic Technology Develops micro chip liquid chromatography cartridges for analysis of complex biological samples |
Electronic Equipment/Instruments
|
Acros Organics BV
 Acros Organics BV Wholesale DistributorsDistribution Services Distributes organic chemicals |
Wholesale Distributors
|
Thermo Fisher Scientific India Pvt Ltd.
 Thermo Fisher Scientific India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products |
Pharmaceuticals: Major
|
Thermo Fisher Scientific India Pvt Ltd.
Thermo Fisher Scientific India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products |
Pharmaceuticals: Major
|
PPD Pharmaceutical Development India Pvt Ltd. |
Other Advanced Medical Equipment & Technology
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.91% | -4.00% | +18.69% | -8.83% | 176B | |
| +0.77% | -0.61% | -24.37% | +32.94% | 149B | |
| -1.25% | +0.89% | -4.09% | -20.94% | 130B | |
| -0.61% | +0.50% | -52.79% | -5.54% | 72.16B | |
| -1.70% | -0.59% | +10.53% | +0.02% | 49.5B | |
| +0.55% | -0.23% | -25.12% | -34.78% | 44.89B | |
| -2.12% | -0.07% | +18.87% | +14.44% | 38.25B | |
| -2.95% | -4.75% | +5.49% | +40.77% | 35.87B | |
| +1.35% | +3.74% | -9.62% | -19.65% | 29.42B | |
| +0.89% | +2.87% | -21.49% | -11.74% | 28.31B | |
| Average | -0.82% | +0.00% | -8.39% | -1.33% | 75.4B | |
| Weighted average by Cap. | -1.06% | -0.76% | -7.00% | -0.29% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TMO Stock
- Company Thermo Fisher Scientific, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition